ZCB-11

N/A

Report date: 2025/01/26 16:22:00

Base Information

Drug NameZCB-11
Drug Alias Nameanti-SARS-CoV-2 antibody (The University of Hong Kong/The Hong Kong University of Science and Technology/AIDS Institute)ZCB-11
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe University Of Hong Kong
China Registration ClassN/A

Develop Information

Active CompaniesHong Kong University Of Science And TechnologyThe AIDS Institute of the University of Hong KongThe University Of Hong Kong
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A